Barber Financial Group, Inc. Genprex, Inc. Transaction History

Barber Financial Group, Inc.

  • $567 Million
  • Q1 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021
SELL
$3.66 - $7.67 $36,600 - $76,700
-10,000 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$2.9 - $4.29 $29,000 - $42,900
10,000 New
10,000 $34,000

Others Institutions Holding GNPX

# of Institutions
2
Shares Held
600
Call Options Held
0
Put Options Held
0
View Full List

About Genprex, Inc.

GNPX Quotes by TradingView
  • Ticker GNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,300
  • Market Cap $17.3M
  • Description
  • Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...
More about GNPX
Track This Portfolio

Track Barber Financial Group, Inc. Portfolio

Follow Barber Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barber Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barber Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email